Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Integrated BioPharma Inc. (INBP) had Stock-Based Compensation of $0.09M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$11.28M |
|
$-0.76M |
|
$11.25M |
|
$0.03M |
|
$12.19M |
|
$-0.91M |
|
$0.04M |
|
$-0.87M |
|
$-0.87M |
|
$-0.76M |
|
$-0.76M |
|
$-0.76M |
|
$-0.76M |
|
$-0.91M |
|
$-0.58M |
|
31.06M |
|
31.06M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$17.82M |
|
$1.76M |
|
$5.73M |
|
$23.55M |
|
$3.54M |
|
$0.09M |
|
$0.24M |
|
$3.78M |
|
$19.77M |
|
$19.77M |
|
$19.77M |
|
31.09M |
|
| Cash Flow Statement Financials | |
$1.92M |
|
$-0.20M |
|
$-0.02M |
|
$3.62M |
|
$5.31M |
|
$1.70M |
|
|
Stock-Based Compensation |
$0.09M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.03 |
|
-- |
|
-- |
|
0.00 |
|
0.01 |
|
0.26% |
|
-8.10% |
|
-8.10% |
|
-- |
|
-7.75% |
|
-6.76% |
|
$1.72M |
|
-- |
|
-- |
|
-- |
|
0.48 |
|
1.35 |
|
3.14 |
|
28.66 |
|
-3.85% |
|
-3.85% |
|
-3.24% |
|
-3.84% |
|
$0.64 |
|
$0.06 |
|
$0.06 |
|